Golhen, K.; Buettcher, M.; Huwyler, J.; van den Anker, J.; Gotta, V.; Dao, K.; Rothuizen, L.E.; Kobylinski, K.; Pfister, M.
Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg. Pharmaceutics 2024, 16, 1186.
https://doi.org/10.3390/pharmaceutics16091186
AMA Style
Golhen K, Buettcher M, Huwyler J, van den Anker J, Gotta V, Dao K, Rothuizen LE, Kobylinski K, Pfister M.
Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg. Pharmaceutics. 2024; 16(9):1186.
https://doi.org/10.3390/pharmaceutics16091186
Chicago/Turabian Style
Golhen, Klervi, Michael Buettcher, Jörg Huwyler, John van den Anker, Verena Gotta, Kim Dao, Laura E. Rothuizen, Kevin Kobylinski, and Marc Pfister.
2024. "Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg" Pharmaceutics 16, no. 9: 1186.
https://doi.org/10.3390/pharmaceutics16091186
APA Style
Golhen, K., Buettcher, M., Huwyler, J., van den Anker, J., Gotta, V., Dao, K., Rothuizen, L. E., Kobylinski, K., & Pfister, M.
(2024). Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg. Pharmaceutics, 16(9), 1186.
https://doi.org/10.3390/pharmaceutics16091186
